文献速递前列腺癌

黑人男性前列腺MRI的阴性预测值:对活检决策的意义

Negative Predictive Value of a Prostate MRI in Black Men: Implications for Biopsy Decision-Making.
PubMed 文献 · J Urol · 2025-03-17

研究前瞻性联合回顾性队列纳入286名黑人男性和965名非黑人男性,评估多参数MRI(mpMRI)对前列腺癌的阴性预测值(NPV)和敏感性。黑人男性PIRADS<3的NPV为77.1% vs 非黑人男性87.6%,敏感性90.7% vs 96.3%(均P<.05)。黑人男性PIRADS 1-2病灶采用PSAD≥0.09 ng/mL/cm3可使敏感性升至92.9%,作者认为该阈值可能更适于安全推迟活检。

要点

  • 黑人男性PIRADS<3的NPV为77.1%,低于非黑人男性的87.6%。
  • 黑人男性PIRADS<3的敏感性为90.7%,低于非黑人男性的96.3%。
  • 黑人男性PIRADS 1-2病灶用PSAD≥0.09 ng/mL/cm3可使敏感性达92.9%。

核心结论

  • 黑人男性PIRADS<3的NPV和敏感性均低于非黑人男性。
  • 对于前列腺MRI阴性(PIRADS 1-2)的黑人男性,PSAD≥0.09 ng/mL/cm3可能是维持≥90%敏感性、安全推迟活检的更好阈值。

研究设计与样本

  • 前瞻性招募2017年至2023年因PSA异常或前列腺检查异常转诊至门诊泌尿外科的黑人和非黑人男性,来自3项相似的生物标志物验证研究,均在MRI引导诊断性前列腺活检前入组。
  • 将研究队列与1家学术机构临床相似的黑人和非黑人男性回顾性临床队列合并,后者也接受了mpMRI和MRI引导活检。
  • MRI采用PIRADS版本2.0或2.1评分。
  • 分析纳入286名黑人男性和965名非黑人男性,PSA≤15.0 ng/mL。

主要发现

  • 在Gleason分级分组2至5的前列腺癌中,黑人男性PIRADS<3的NPV为77.1%,非黑人男性为87.6%(P<.05)。
  • 黑人男性PIRADS<3的敏感性为90.7%,非黑人男性为96.3%(P<.05)。
  • 黑人男性PIRADS 1至2病灶采用PSAD≥0.09 ng/mL/cm3,敏感性提高至92.9%。

关键数值与推荐

  • 黑人男性PIRADS<3:NPV 77.1%,敏感性90.7%(Gleason分级分组2-5前列腺癌)。
  • 非黑人男性PIRADS<3:NPV 87.6%,敏感性96.3%(Gleason分级分组2-5前列腺癌)。
  • 黑人男性PIRADS 1-2病灶联合PSAD≥0.09 ng/mL/cm3:敏感性92.9%。

临床怎么用

  • 作者认为,对于前列腺MRI阴性(PIRADS 1-2)的黑人男性,PSAD≥0.09 ng/mL/cm3可能是维持≥90%敏感性、安全推迟活检的更好阈值。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Prostate Imaging Reporting and Data System (PIRADS) v2.1 scoring with multiparametric (mp) MRI has a pooled 90% negative predictive value (NPV). PSA density (PSAD) ≤ 0.15 ng/mL/cm3 has been shown to enhance mpMRI's NPV in non-Black men. Populations with higher disease prevalence are known to have lower NPVs. Given that Black men have higher prostate cancer prevalence, we evaluate sensitivity and NPV of mpMRI in Black vs non-Black men to assess possible mpMRI performance differences. As an exploratory objective, we investigate PSAD thresholds providing ≥ 90% sensitivity in Black men. MATERIALS AND METHODS: We prospectively recruited Black and non-Black men referred to outpatient urology clinics for abnormal PSA or prostate examination in 3 similar biomarker validation studies from 2017 to 2023 before MRI-informed diagnostic prostate biopsy. We combined the research cohorts with a retrospective clinical cohort of clinically similar Black and non-Black men from 1 academic institution who also underwent mpMRIs and MRI-informed biopsies. MRIs were scored using PIRADS version 2.0 or 2.1. RESULTS: Our analysis included 286 Black men and 965 non-Black men with PSA ≤ 15.0 ng/mL. PIRADS < 3 had an NPV of 77.1% vs 87.6% and a sensitivity of 90.7% vs 96.3% for Gleason grade group 2 to 5 prostate cancer in Black vs non-Black men, respectively (both P < .05). Using PSAD ≥ 0.09 for Black men with PIRADS 1 to 2 lesions increased sensitivity to 92.9%. CONCLUSIONS: PIRADS < 3 has a lower NPV and sensitivity in Black men. For negative prostate MRIs, PSAD ≥ 0.09 may be a better threshold for safe biopsy deferral in Black men to maintain a ≥ 90% sensitivity.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Sandlow S, Carbunaru S, Sun Z, et al. Negative Predictive Value of a Prostate MRI in Black Men: Implications for Biopsy Decision-Making. J Urol. 2025. PMID: 40096657. doi:10.1097/JU.0000000000004498

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。